Insulin in critical care settings
Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 3
Abstract
Inpatient hyperglycemia is common and is associated with an increased risk of hospital complications, higher costs, and higher in-hospital morbidity & mortality rates. Appropriate glycemic control strategies can reduce these risks, although hypoglycemia is a concern. In critically ill patients, intravenous (IV) insulin is most appropriate, with a starting threshold no higher than 180 mg/dL. Once IV insulin is started, the glucose level should be maintained between 140 and 180 mg/dL.
Authors and Affiliations
Sameer Aggarwal, Vineet Surana
Guideline based management of community acquired pneumonia
Pneumonia is a common clinical condition confronted by general practitioners as well as chest physicians1. The annual incidence varies in different age groups. It is common in children aged <5 years and in elderly people...
An analysis of 30 cases of myelodysplastic syndrome
30 Cases of MDS presented from April 98 to May 2006 are included in this study. 15 cases were male and 15 cases were female. Mean age at presentation was 55 years (range 8-73 years). Majority of patients presented with w...
Angiotensin receptor / neprilysin inhibitors (ARNIs) : the new hope in the management of heart failure
Heart failure (HF) represents major challenges in cardiovascular disease and despite newer therapeutic advances, mortality still remains high. Inhibition of neurohumoural pathways such as the renin angiotensin aldosteron...
Ileal Tricho-phytobezoar a rare cause of intestinal obstruction : a case report
A bezoar is a ball of swallowed foreign material that collects in the gastrointestinal tract and usually fails to passs through. Trichobezoar (hair) and phytobezoar (vegetable fibres) are the most frequent forms. Rarely...
Post-transplant human cytomegalovirus infection can lead to deterioration and dysfunction of renal allograft tissue
Human Cytomegalovirus (HCMV) infection could lead to a renal allograft failure in post-transplant recipients even after a successful histocompatibility match and absence of donor specific preexisting antibody. The tentat...